Class II · Moderate riskTerminated Initiated Apr 13, 2022 (4 years ago)
MethyLPREDNISolone Acetate Injectable Suspension USP, 40 mg/mL, packaged in a) single…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
cGMP deviations: Temperature abuse
What was recalled
MethyLPREDNISolone Acetate Injectable Suspension USP, 40 mg/mL, packaged in a) single dose vial (NDC 6714-088-01) b) 25-count box (NDC16714-088-25), Rx only, MFG: NorthstarRx/Teva Pharma USA
Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office
NDC code
6714-088-01
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1061-2022
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing…
Reason Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary…
Amneal Pharmaceuticals of New York, LLCNDC 70121-1574-01D-0756-2023